Assessment of State and Federal Health Policies for Opioid Use Disorder Treatment During the COVID-19 Pandemic and Beyond
Link
Description
Examines state-level policy data from government and nonprofit agencies related to treatment access and treatment retention for patients with Opioid Use Disorder (OUD) during the COVID-19 pandemic. Describes policy changes affecting telehealth coverage, delivery, and payment; issues of licensing and security; and the initiation and dispensing of treatment medications.
Author(s)
Seema Chosky Pessar, Anne Boustead, Yimin Ge, Rosanna Smart, Rosalie Liccardo Pacula
Citation
JAMA Health Forum, 2(11), e213833
Date
11/2021
Tagged as
Access
· COVID-19
· Illicit drug use
· Policy
· Prescription drug misuse
· Reimbursement and payment models
· Telehealth